Table 2.
Anthropometric measures at baseline (ITT: number (N) = 64) in groups to be treated with polyglucosamine and orlistat
| Variable | Total | Group polyglucosamine | Group orlistat | pa/b |
|---|---|---|---|---|
| N | 64 | 32 | 32 | |
| Gender (male/female) | 28/36 | 16/16 | 12/20 | P = 0.313a |
| Age (years) | 50.0 ± 9.17 | 50.0 ± 9.10 | 50.1 ± 9.38 | P = 0.989b |
| Weight (kg) | 99.4 ± 12.33 | 100.6 ± 13.22 | 98.2 ± 11.47 | P = 0.446b |
| Height (m) | 169.3 ± 8.09 | 170.3 ± 7.60 | 168.4 ± 8.58 | P = 0.358b |
| BMI (kg/m2) | 34.7 ± 4.21 | 34.6 ± 3.70 | 34.8 ± 4.73 | P = 0.896b |
| WC (cm) | 111.2 ± 10.66 | 112.4 ± 10.95 | 110.0 ± 10.38 | P = 0.358b |
aChi square test; bt test